Hyperspectral Imaging for Prediction of Preeclampsia
Recruiting
Observational Study
Preeclampsia (PE) Risk
Preeclampsia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 1,430 (estimated)
- Sponsor
- Heidelberg University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Preeclampsia is a hypertensive pregnancy disorder that can quickly lead to serious, potentially life-threatening outcomes for both the mother and the fetus. Typical features of preeclampsia are by endothelial and microvascular dysfunctionsNotably, such impairments in endothelial function may precede preeclampsia diagnosis and canpersist for years postpartum. In clinical practice, however, no predi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* singleton pregnancies
* age ≥ 18 years
* patient's ability to provide consent
* written informed consent
* women scheduled for a routine ultrasound scan in first or second trimester
Exclusion Criteria:
* lack of consent
* language barrier
* severe fetal chromosomal/genetic/s…
Contacts
Alexandra von Au, MD
CONTACT